Lobbying Filing Details

Total Spending

$60,000

Activities

2

Lobbyists

3

Gov't Entities

4

Filing Information
Filing UUID:
fa8f3e49-b131-406e-ae3a-c4f223e7e8bf
Type:
Q1 - 1st Quarter - Report
Period:
2026 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 20, 2026 at 9:30 PM
Income:
$60,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Jonathon Jones, Partner
Registrant
TIBER CREEK GROUP

Government Relations.

Washington, District of Columbia
Client
ASTELLAS PHARMA US, INC.

Pharmacuetical company.

District of Columbia, United States of America
Lobbying Activities (2)
Activity 1
Health Issues

Issues related to the implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to oncology; Issues related to ophthalmology; Issues related to the One Big Beautiful Bill Act (PL 119-21).

Lobbyists (3)
  • JONATHON JONES
  • JOHN MICHAEL GONZALEZ
  • COREY MALMGREN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Medicare/Medicaid

Issues related to the implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the One Big Beautiful Bill Act (PL 119-21).

Lobbyists (3)
  • JONATHON JONES
  • JOHN MICHAEL GONZALEZ
  • COREY MALMGREN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.